VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+8.1%
5Y CAGR+21.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+8.1%/yr
vs +18.5%/yr prior
5Y CAGR
+21.2%/yr
Recent deceleration
Acceleration
-10.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$18.53M+8.5%
2025$17.08M+21.5%
2024$14.06M-4.1%
2023$14.66M+10.7%
2022$13.25M+86.6%
2021$7.10M+8.4%
2020$6.55M-11.9%
2019$7.43M+15.5%
2018$6.44M+9.7%
2017$5.87M-